Park Place Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05K | Hold |
16
| – | – | ﹤0.01% | 728 |
|
|
2025
Q1 | $1.77K | Hold |
16
| – | – | ﹤0.01% | 746 |
|
|
2024
Q4 | $2.18K | Hold |
16
| – | – | ﹤0.01% | 723 |
|
|
2024
Q3 | $1.84K | Hold |
16
| – | – | ﹤0.01% | 775 |
|
|
2024
Q2 | $2.2K | Hold |
16
| – | – | ﹤0.01% | 763 |
|
|
2024
Q1 | $2.21K | Hold |
16
| – | – | ﹤0.01% | 813 |
|
|
2023
Q4 | $2.11K | Hold |
16
| – | – | ﹤0.01% | 794 |
|
|
2023
Q3 | $1.8K | Hold |
16
| – | – | ﹤0.01% | 934 |
|
|
2023
Q2 | $1.51K | Sell |
16
-705
| -98% | -$66.5K | ﹤0.01% | 972 |
|
|
2023
Q1 | $73K | Buy |
721
+9
| +1% | +$911 | 0.02% | 418 |
|
|
2022
Q4 | $85K | Buy |
+712
| New | +$85K | 0.02% | 384 |
|